Patient-Reported Changes in Alcohol Use Following Glucagon-Like Peptide-1 Receptor Agonist Initiation
This survey study with a nationally representative sample evaluates whether individuals who initiate glucagon-like peptide-1 receptor agonists (GLP-1 RAs) report reducing alcohol consumption after starting the drug.
Authors
- Shelly F. Greenfield (ORCID: https://orcid.org/0000-0002-9387-1416)
- Haiden A. Huskamp (ORCID: https://orcid.org/0000-0002-1860-3956)
- Dominic Hodgkin (ORCID: https://orcid.org/0000-0002-4494-9176)
- Alisa B. Busch (ORCID: https://orcid.org/0000-0002-1828-9098)
- Andrew J. Muzyk (ORCID: https://orcid.org/0000-0002-6904-2466)
- Lori Uscher‐Pines (ORCID: https://orcid.org/0000-0002-8816-0986)
- Ateev Mehrotra (ORCID: https://orcid.org/0000-0003-2223-1582)
- Jessica Sousa
Institutions
- RAND Corporation (US)
- Harvard University (US)
- Duke University (US)
- Brown University (US)
- McLean Hospital (US)
- Brandeis University (US)
Publication Details
- Journal
- JAMA Psychiatry
- Published
- 2026-10-14
- DOI
- https://doi.org/10.1001/jamapsychiatry.2026.3242
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00